id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1975-N-0012-0196,FDA,FDA-1975-N-0012,Citizen Petition from Ciba Specialty Chemicals Corporation,Other,Citizen Petition,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2017-11-22T17:13:28Z,,0,0,09000064805c1b33
FDA-1975-N-0012-0197,FDA,FDA-1975-N-0012,Acknowledgment Letter from FDA/DDM to Ciba Specialty Chemicals Corporation,Other,Acknowledgement Letter/Receipt,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2017-11-27T15:57:51Z,,0,0,09000064805c1b34
FDA-1975-N-0012-0198,FDA,FDA-1975-N-0012,Supplement from Ciba Specialty Chemicals Corporation,Other,Supplement (SUP),2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2017-11-22T17:41:18Z,,0,0,09000064805c1b35
FDA-2012-S-1178-0015,FDA,FDA-2012-S-1178,"NDI 734, Heat-Killed Lactobacillus Plantarum L-137 (HK-LP), Immuno-LP20  from House Wellness Foods Corporation",Other,75 Day PreMarket Notification,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2016-10-27T15:19:56Z,,0,0,0900006481199880
FDA-2012-S-1178-0017,FDA,FDA-2012-S-1178,"NDI 736, Tall Oil Phytoesters from Forbes Medi-Tech Corporation",Other,75 Day PreMarket Notification,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2016-10-27T15:19:56Z,,0,0,0900006481199883
FDA-1980-N-0004-0008,FDA,FDA-1980-N-0004,"Acknowledgement Letter to Ferenc Kuhn, M.D., Ph.D. and Wendell J. Scott M.D.",Other,Acknowledgement Letter/Receipt,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2012-12-31T19:33:40Z,,0,0,090000648119e74e
FDA-1980-N-0004-0007,FDA,FDA-1980-N-0004,"Citizen Petition from Ferenc Kuhn, MD., Ph.D. and Wendell J. Scott M.D.",Other,Citizen Petition,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2024-11-12T05:09:22Z,,1,0,090000648119e74c
FDA-2012-P-1265-0001,FDA,FDA-2012-P-1265,Indicus Pharma LLC - Citzen Petition,Other,Citizen Petition,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2019-01-19T02:05:18Z,,0,0,090000648119e750
FDA-2012-P-1265-0002,FDA,FDA-2012-P-1265,Acknowledgement Letter to Indicus Pharma LLC,Other,Acknowledgement Letter/Receipt,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2012-12-31T19:12:37Z,,0,0,090000648119e753
FDA-2012-E-1245-0001,FDA,FDA-2012-E-1245,"The Henry M. Jackson Foundation for the Advancement of Military Meicine (Finnegan, Henderson, et al) - Patent Extension Application",Other,Application,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2012-12-31T21:46:33Z,,0,0,09000064811a0ce5
FDA-1975-N-0012-0194,FDA,FDA-1975-N-0012,Citizen Petition from Bayer Corporation,Other,Citizen Petition,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2017-11-27T15:04:09Z,,0,0,09000064805c1b30
FDA-1975-N-0012-0221,FDA,FDA-1975-N-0012,Supplement from Aplicare Inc.,Other,Supplement (SUP),2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2017-10-30T15:11:18Z,,0,0,09000064805c1c9b
FDA-2012-E-1244-0002,FDA,FDA-2012-E-1244,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2012-12-31T21:17:55Z,,0,0,09000064811a0ce3
FDA-2012-P-0661-0003,FDA,FDA-2012-P-0661,"Interim Response Letter from FDA CDER to Sandoz, Inc.",Other,Letter(s),2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2019-03-14T17:26:53Z,,0,0,09000064811a0c2e
FDA-1975-N-0012-0195,FDA,FDA-1975-N-0012,Acknowledgment Letter from FDA/DDM to Bayer Corporation,Other,Acknowledgement Letter/Receipt,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2017-10-24T19:34:23Z,,0,0,09000064805c1b31
FDA-2012-S-1178-0019,FDA,FDA-2012-S-1178,"NDI 738, Antrodia Cinnamomea Extract from WinPal LLC",Other,75 Day PreMarket Notification,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2016-10-27T15:19:56Z,,0,0,0900006481199885
FDA-2012-P-1267-0001,FDA,FDA-2012-P-1267,"Xspire Pharma, LLC - Citizen Petition",Other,Citizen Petition,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2024-11-12T05:11:10Z,,1,0,090000648119ff73
FDA-2010-P-0188-0016,FDA,FDA-2010-P-0188,"AXIN, Veltrop & Harkrider LLP (Actavis Elizabeth LLC) - Withdrawal of Citizen Petition",Other,Withdrawal,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2012-12-31T17:34:48Z,,0,0,09000064811a0997
FDA-2012-S-1178-0016,FDA,FDA-2012-S-1178,"NDI 735, Euphovida (3-Phytase), EUPHOVIDA TM from DSM Food Specialties",Other,75 Day PreMarket Notification,2012-12-31T05:00:00Z,2012,12,,,2016-10-27T15:19:56Z,,0,0,0900006481199882
FDA-2012-E-1244-0001,FDA,FDA-2012-E-1244,"The Henry M. Jackson Foundation for the Advancement of Military Meicine (Finnegan, Henderson, et al) - Patent Extension Application",Other,Application,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2012-12-31T21:39:13Z,,0,0,09000064811a0cc1
FDA-2012-S-1178-0018,FDA,FDA-2012-S-1178,"NDI 737, Syringa Vulgaris Extract, I.R.B. lstituto di Ricerche Biotecnologiche S.p.A.",Other,75 Day PreMarket Notification,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2016-10-27T15:19:56Z,,0,0,0900006481199884
FDA-2012-E-1245-0002,FDA,FDA-2012-E-1245,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2012-12-31T21:46:33Z,,0,0,09000064811a0ce7
FDA-2012-P-1267-0002,FDA,FDA-2012-P-1267,"Acknowledgement Letter to Xspire Pharma, LLC",Other,Acknowledgement Letter/Receipt,2012-12-31T05:00:00Z,2012,12,2012-12-31T05:00:00Z,,2012-12-31T19:41:32Z,,0,0,090000648119ff76
FDA-2012-P-1259-0001,FDA,FDA-2012-P-1259,Hyman Phelps McNamara PC - Citizen Petition,Other,Citizen Petition,2012-12-30T05:00:00Z,2012,12,2012-12-30T05:00:00Z,,2024-11-12T05:11:55Z,,1,0,090000648119d635
FDA-2012-P-1259-0002,FDA,FDA-2012-P-1259,"Acknowledgement Letter to Hyman, Phelps & McNamara, PC",Other,Acknowledgement Letter/Receipt,2012-12-30T05:00:00Z,2012,12,2012-12-30T05:00:00Z,,2012-12-31T01:04:14Z,,0,0,090000648119d736
FDA-2011-E-0133-0007,FDA,FDA-2011-E-0133,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2024-03-13T11:51:10Z,,0,0,090000648119d5e1
FDA-2012-E-1237-0001,FDA,FDA-2012-E-1237,"Genentech, Inc. (Morrison & Foerster LLP) - Patent Extension Application",Other,Application,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T16:13:29Z,,0,0,090000648119df04
FDA-2012-E-1236-0001,FDA,FDA-2012-E-1236,"Genentech, Inc. (Morrison & Foerster LLP) - Patent Extension Application",Other,Application,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T14:44:12Z,,0,0,090000648119dbad
FDA-1995-S-0036-0135,FDA,FDA-1995-S-0036,"Resuscitation Outcomes Consortium (ROC) re IND 110280, British Columbia, Canada Public Disclosure Material Report 63 - Report",Other,Report,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2014-11-28T19:44:04Z,,0,0,090000648118f830
FDA-2011-E-0153-0007,FDA,FDA-2011-E-0153,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T14:09:25Z,,0,0,090000648119d582
FDA-2010-E-0399-0008,FDA,FDA-2010-E-0399,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T14:49:24Z,,0,0,090000648119d5de
FDA-2007-E-0482-0009,FDA,FDA-2007-E-0482,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T12:41:20Z,,0,0,090000648119d087
FDA-2007-E-0278-0013,FDA,FDA-2007-E-0278,"FDA/CDER to Covington & Burling LLP (Merck & Co., Inc.) - Letter",Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T14:23:52Z,,0,0,090000648119d5dc
FDA-2012-E-1235-0002,FDA,FDA-2012-E-1235,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T14:01:20Z,,0,0,090000648119d26b
FDA-2012-E-1237-0002,FDA,FDA-2012-E-1237,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T16:13:31Z,,0,0,090000648119e02b
FDA-2011-E-0136-0008,FDA,FDA-2011-E-0136,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2024-03-13T11:49:37Z,,0,0,090000648119d5e4
FDA-1995-S-0036-0136,FDA,FDA-1995-S-0036,"University of Texas Health Science Center at Houston re IND 14929, University of Alabama Public Disclosure Material Report 64 - Report",Other,Report,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2014-11-28T19:44:18Z,,0,0,090000648118f832
FDA-2010-E-0663-0006,FDA,FDA-2010-E-0663,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T13:09:35Z,,0,0,090000648119d090
FDA-1995-S-0036-0137,FDA,FDA-1995-S-0036,"Rampart Neurological  Emergencies Treatment Trials Neuro Emergencies Research, Community Consultion and Public Disclosure IND 102254 Report 65 - Report",Other,Report,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2014-11-28T19:44:31Z,,0,0,090000648119e1fd
FDA-2012-E-1241-0003,FDA,FDA-2012-E-1241,"Abbott Cardiovascular Systems Inc. (Baker Botts, LLP) - Supplement",Other,Supplement (SUP),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T17:24:52Z,,0,0,090000648119e0e9
FDA-2012-V-1222-0002,FDA,FDA-2012-V-1222,Acknowledgement Letter to Simply Automation,Other,Acknowledgement Letter/Receipt,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T15:16:11Z,,0,0,090000648118faf9
FDA-2012-E-1234-0001,FDA,FDA-2012-E-1234,"Mitsubishi Tenabe Pharma Corp. (Finnegan, Henderson, Farabow, Garrett & Dunner LLP) - Patent Extension Application",Other,Application,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T13:10:24Z,,0,0,090000648119d265
FDA-2012-E-1236-0002,FDA,FDA-2012-E-1236,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T14:44:12Z,,0,0,090000648119dbaf
FDA-2012-E-1241-0001,FDA,FDA-2012-E-1241,"Abbott Cardiovascular Systems Inc. (Baker Botts, LLP) - Patent Extension Application",Other,Application,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T17:24:50Z,,0,0,090000648119e0e4
FDA-2012-E-1243-0002,FDA,FDA-2012-E-1243,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T21:50:47Z,,0,0,090000648119eb02
FDA-2012-E-1235-0001,FDA,FDA-2012-E-1235,"Genentech, Inc. (Morrison & Foerster LLP) - Patent Extension Application",Other,Application,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T14:01:19Z,,0,0,090000648119d269
FDA-2012-V-1222-0001,FDA,FDA-2012-V-1222,Simply Automation - Application for Variance,Other,Application for Variance (VAR),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T15:16:10Z,,0,0,090000648118faa9
FDA-2012-E-1234-0002,FDA,FDA-2012-E-1234,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T13:10:25Z,,0,0,090000648119d267
FDA-2011-E-0139-0007,FDA,FDA-2011-E-0139,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T13:00:15Z,,0,0,090000648119d08b
FDA-2011-E-0371-0007,FDA,FDA-2011-E-0371,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T13:21:29Z,,0,0,090000648119d57c
FDA-2011-E-0168-0007,FDA,FDA-2011-E-0168,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2024-03-13T11:33:47Z,,0,0,090000648119d580
FDA-2010-E-0049-0007,FDA,FDA-2010-E-0049,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T12:50:18Z,,0,0,090000648119d089
FDA-2011-E-0379-0007,FDA,FDA-2011-E-0379,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T13:27:04Z,,0,0,090000648119d57e
FDA-2012-E-1243-0001,FDA,FDA-2012-E-1243,Durand Wayland Inc. (Altera Law Group LLC) - Patent Extension Application,Other,Application,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T21:50:46Z,,0,0,090000648119eadf
FDA-2012-E-1241-0002,FDA,FDA-2012-E-1241,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T17:24:51Z,,0,0,090000648119e0e6
FDA-2012-S-1178-0009,FDA,FDA-2012-S-1178,"NDI 727 17a-Hydroxypregna-1,4-Diene-3,20-Dione 1,4-Diene from  Proprietary Wellness",Other,75 Day PreMarket Notification,2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2016-10-27T15:19:55Z,,0,0,0900006480fac72b
FDA-2012-E-1246-0001,FDA,FDA-2012-E-1246,"Medtronic, Inc. (Sterne Kessler Goldstein & Fox PLLC) - Patent Extension Application",Other,Application,2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T23:16:14Z,,0,0,090000648119cae1
FDA-2001-V-0062-0009,FDA,FDA-2001-V-0062,"FDA/CDRH to DayStar Lasers International, LLC - Approval for Variance",Other,Approval for Variance (VRA),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T16:35:26Z,,0,0,090000648119b78c
FDA-2012-E-1233-0002,FDA,FDA-2012-E-1233,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-28T00:24:28Z,,0,0,090000648119ceef
FDA-2012-E-1226-0002,FDA,FDA-2012-E-1226,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T23:14:08Z,,0,0,090000648119ce85
FDA-2012-E-1232-0002,FDA,FDA-2012-E-1232,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T23:56:54Z,,0,0,090000648119ce89
FDA-2012-E-1232-0001,FDA,FDA-2012-E-1232,"Arena Pharmaceuticals, Inc. (Finnegan Henderson LLP) - Patent Extension Application",Other,Application,2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T23:56:33Z,,0,0,090000648119ce87
FDA-2012-S-1178-0011,FDA,FDA-2012-S-1178,"NDI 729, HT 1001: Panax quinquefolius (American ginseng) from Afexa Life Sciences, Inc.",Other,75 Day PreMarket Notification,2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2016-10-27T15:19:55Z,,0,0,0900006480fac757
FDA-2012-S-1178-0010,FDA,FDA-2012-S-1178,NDI 728 Terminalia chebula from Hikmeth Corporation,Other,75 Day PreMarket Notification,2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2016-10-27T15:19:55Z,,0,0,0900006480fac748
FDA-2011-E-0152-0007,FDA,FDA-2011-E-0152,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T18:17:27Z,,0,0,090000648119c9b4
FDA-2010-E-0334-0009,FDA,FDA-2010-E-0334,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T15:16:22Z,,0,0,090000648119c5b0
FDA-2010-E-0662-0006,FDA,FDA-2010-E-0662,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T19:53:47Z,,0,0,090000648119cadb
FDA-2012-E-1247-0002,FDA,FDA-2012-E-1247,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T22:11:52Z,,0,0,090000648119ce81
FDA-2010-E-0659-0008,FDA,FDA-2010-E-0659,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T14:53:05Z,,0,0,090000648119c5ac
FDA-2011-E-0246-0007,FDA,FDA-2011-E-0246,FDA\CDER to U.S. Patent and Trademark Office Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T16:46:12Z,,0,0,090000648119c8d0
FDA-2011-E-0245-0007,FDA,FDA-2011-E-0245,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2024-03-13T11:31:53Z,,0,0,090000648119c8ce
FDA-2011-E-0389-0008,FDA,FDA-2011-E-0389,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T15:51:29Z,,0,0,090000648119c7d6
FDA-2012-S-1178-0014,FDA,FDA-2012-S-1178,"NDI 733, E. Coli Strain Nissle 1917 and Mutaflor from Medical Futures Inc.",Other,75 Day PreMarket Notification,2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2016-10-27T15:19:56Z,,0,0,09000064811961c4
FDA-2012-E-1246-0002,FDA,FDA-2012-E-1246,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T21:16:32Z,,0,0,090000648119cc3c
FDA-2012-V-1078-0003,FDA,FDA-2012-V-1078,FDA/CDRH to Nicky-B Entertainment - Approval for Variance,Other,Approval for Variance (VRA),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T17:10:11Z,,0,0,090000648119b800
FDA-2011-E-0380-0008,FDA,FDA-2011-E-0380,FDA\CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T15:45:07Z,,0,0,090000648119c5b5
FDA-2011-E-0113-0007,FDA,FDA-2011-E-0113,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T20:10:42Z,,0,0,090000648119cadd
FDA-2012-S-1178-0012,FDA,FDA-2012-S-1178,"NDI 731, 3,5-Diiodo-L-Thryonine and Proprietary Wellness",Other,75 Day PreMarket Notification,2012-12-27T05:00:00Z,2012,12,2011-10-05T04:00:00Z,,2016-10-27T15:19:55Z,,0,0,09000064811961bd
FDA-2011-E-0156-0007,FDA,FDA-2011-E-0156,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2024-03-13T11:35:54Z,,0,0,090000648119c23a
FDA-2011-E-0114-0007,FDA,FDA-2011-E-0114,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2024-03-13T11:58:33Z,,0,0,090000648119c7dd
FDA-2011-E-0014-0007,FDA,FDA-2011-E-0014,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2024-03-13T12:03:47Z,,0,0,090000648119c23f
FDA-2010-E-0333-0009,FDA,FDA-2010-E-0333,FDA\CDER to U.S. Patent and Trademark Office Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T15:24:03Z,,0,0,090000648119c5b2
FDA-2012-D-1197-0005,FDA,FDA-2012-D-1197,"The Honorable Pete Olson et al to the Commissioner, FDA - Letter",Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2013-02-28T21:04:16Z,,0,0,090000648119b8ac
FDA-2010-E-0660-0007,FDA,FDA-2010-E-0660,FDA\CDER to U.S. Patent and Trademark Office - Lettero,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T15:02:27Z,,0,0,090000648119c5ae
FDA-2012-P-1180-0003,FDA,FDA-2012-P-1180,"Lannett Company, Inc. - Amendment",Other,Amendment,2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-28T02:52:05Z,,0,0,090000648119cd8a
FDA-2012-E-1247-0001,FDA,FDA-2012-E-1247,"Arena Pharmaceuticals Inc. (Finnegan, Henderson, Farabow, Garrett & Dunner, LLP) - Patent Extension Application",Other,Application,2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T22:11:52Z,,0,0,090000648119cde1
FDA-2012-E-1233-0001,FDA,FDA-2012-E-1233,"Toshiaki Miyake, et al (Wenderoth, Lind & Ponack LLP) - Patent Extension Application",Other,Application,2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-28T00:24:28Z,,0,0,090000648119ceed
FDA-2011-E-0141-0008,FDA,FDA-2011-E-0141,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2024-03-13T12:14:04Z,,0,0,090000648119ca05
FDA-2012-E-1226-0001,FDA,FDA-2012-E-1226,"LEO Laboratories (Edwards, Wildman, Palmer LLP) - Patent Extension Application",Other,Application,2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T23:11:19Z,,0,0,090000648119ce83
FDA-2010-E-0661-0007,FDA,FDA-2010-E-0661,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T19:42:58Z,,0,0,090000648119ca07
FDA-2012-V-1008-0003,FDA,FDA-2012-V-1008,FDA/CDRH to Sound and Lighting Designs - Approval for Variance,Other,Approval for Variance (VRA),2012-12-27T05:00:00Z,2012,12,2012-12-27T05:00:00Z,,2012-12-27T17:18:33Z,,0,0,090000648119b804
FDA-2012-P-0695-0009,FDA,FDA-2012-P-0695,Interim Response to Lorillard Tobacco Company,Other,Letter(s),2012-12-26T05:00:00Z,2012,12,2012-12-26T05:00:00Z,,2012-12-26T15:13:51Z,,0,0,090000648119a1e3
FDA-2012-P-0779-0005,FDA,FDA-2012-P-0779,"FDA/CDER to Valeant Pharmaceuticals Intl., Inc. - Petition Denial Correction",Other,Correction(s),2012-12-26T05:00:00Z,2012,12,2012-12-26T05:00:00Z,,2012-12-26T18:20:49Z,,0,0,090000648119ab94
EPA-HQ-OA-2012-0987-0002,EPA,EPA-HQ-OA-2012-0987,Regulatory Plan - Fall 2012,Other,Memorandum to Open a Docket,2012-12-24T05:00:00Z,2012,12,2012-12-24T05:00:00Z,,2013-01-31T16:16:13Z,,0,0,0900006481199110
EPA-HQ-OA-2012-0987-0001,EPA,EPA-HQ-OA-2012-0987,Semiannual Regulatory Agenda - Fall 2012,Other,Memorandum to Open a Docket,2012-12-24T05:00:00Z,2012,12,2012-12-24T05:00:00Z,,2013-01-31T16:15:52Z,,0,0,090000648119910f
FDA-1978-N-0023-0166,FDA,FDA-1978-N-0023,Report from Nonprescription Drug Manufacturers Association,Other,Report,2012-12-24T05:00:00Z,2012,12,2012-12-24T05:00:00Z,,2019-09-25T19:25:17Z,,0,0,090000648055f19c
FDA-1978-N-0023-0167,FDA,FDA-1978-N-0023,Acknowledgment Letter from FDA DDM to Michael T. Benson,Other,Acknowledgement Letter/Receipt,2012-12-24T05:00:00Z,2012,12,,,2019-09-13T15:31:17Z,,0,0,0900006480a3d7cf
FDA-1978-N-0023-0168,FDA,FDA-1978-N-0023,"Supplement from Paul A. Lehman, M.Sc.  and Thomas J. Franz, M.D.",Other,Supplement (SUP),2012-12-24T05:00:00Z,2012,12,2012-12-24T05:00:00Z,,2019-09-16T13:33:03Z,,0,0,090000648055fd10
USDA-2012-0005-0001,USDA,USDA-2012-0005,Semiannual Regulatory Agenda - Fall 2012,Other,,2012-12-24T05:00:00Z,2012,12,2012-12-24T05:00:00Z,,2013-01-12T22:29:33Z,,0,0,090000648119935d
USDA-2012-0005-0002,USDA,USDA-2012-0005,Regulatory Plan - Fall 2012,Other,,2012-12-24T05:00:00Z,2012,12,2012-12-24T05:00:00Z,,2012-12-27T19:15:34Z,,0,0,090000648119935e